Researchers have discovered a distinctive signature in the human brain associated with the effects of psychedelic substances, revealing how these drugs alter perception and consciousness.
This “neural fingerprint” was identified through an extensive analysis of numerous brain scans from individuals under the influence of LSD, psilocybin, DMT, mescaline, and ayahuasca, indicating a common effect on brain function.
The findings stem from a comprehensive study that integrated 11 brain imaging datasets globally, aiming to create a clearer understanding of the temporary restructuring induced by these substances in the brain.
These revelations are becoming increasingly crucial as scientists explore the therapeutic potential of psychedelics for serious mental health and neurological disorders, including depression, schizophrenia, and post-traumatic stress disorder.
Dr. Danilo Bzdok, a senior researcher from McGill University in Montreal, Canada, noted, “These five substances, which have not been previously analyzed collectively for their effects on the brain, share certain commonalities in how they alter brain function.” He elaborated that, “All five substances disrupt the usual order of brain systems, essentially flattening the hierarchy, which likely contributes to what some individuals describe as a profound connection with their own consciousness.”
For years, scientists have endeavored to comprehend how psychedelics generate hallucinations and sensations of self-dissolution, where individuals perceive a fragmentation of their identity. However, past studies have often been limited in size, making it difficult to draw definitive conclusions.
In a paper published in Nature Medicine, Bzdok and his team reviewed over 500 brain scans from 267 participants across five countries, which they regard as the most extensive investigation into psychedelics and their effects on the brain to date.
While some variations in brain activity were noted among the different drugs, significant similarities emerged in the ways these substances influenced inter-regional brain communication. Notably, there was enhanced interaction between networks associated with advanced cognitive functions and those linked to basic sensory and visual processing.
Dr. Bzdok remarked, “There is a remarkable level of interaction between different brain systems; they are communicating in an unprecedented manner. This excessive cross-talk is indicative of the altered state induced by psychedelics.”
Moreover, the study revealed additional changes in deeper brain regions associated with habits, learning, and motor functions. Contrary to some earlier assertions, the research found minimal evidence supporting the notion that specific brain networks “disintegrate” under the influence of psychedelics.
Bzdok emphasized that this study provides a more robust foundation for psychedelic research, which is essential for the potential integration of these drugs into mainstream mental health treatments. “This field is evolving, but it remains precarious; it’s like constructing buildings on unstable ground,” he stated. “Our goal was to establish a solid basis for future research.”
Dr. Emmanuel Stamatakis, a senior co-author from the University of Cambridge, underscored the rapid progression of this field, asserting, “For psychedelic research to advance responsibly, it requires comprehensive, coordinated evidence from large-scale studies.”
